IRIS
PERRICONE, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 59.407
AS - Asia 6.727
EU - Europa 5.928
SA - Sud America 861
Continente sconosciuto - Info sul continente non disponibili 749
AF - Africa 132
OC - Oceania 97
Totale 73.901
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 59.127
SG - Singapore 3.092
CN - Cina 1.483
DE - Germania 834
IT - Italia 829
RU - Federazione Russa 815
BR - Brasile 726
UA - Ucraina 700
FR - Francia 599
IE - Irlanda 589
HK - Hong Kong 581
FI - Finlandia 511
VN - Vietnam 484
GB - Regno Unito 347
SE - Svezia 278
BD - Bangladesh 231
JP - Giappone 178
KR - Corea 169
CA - Canada 147
IN - India 111
PL - Polonia 77
NL - Olanda 76
BE - Belgio 64
MX - Messico 63
AU - Australia 53
ES - Italia 49
ID - Indonesia 48
NZ - Nuova Zelanda 43
AR - Argentina 42
TW - Taiwan 42
ZA - Sudafrica 42
DK - Danimarca 37
IQ - Iraq 36
UZ - Uzbekistan 35
TR - Turchia 31
IR - Iran 30
PK - Pakistan 29
EC - Ecuador 24
MY - Malesia 24
SA - Arabia Saudita 23
AT - Austria 20
EG - Egitto 19
MA - Marocco 19
PH - Filippine 19
CO - Colombia 18
AE - Emirati Arabi Uniti 17
LT - Lituania 16
CL - Cile 15
JM - Giamaica 14
RO - Romania 13
LV - Lettonia 11
CZ - Repubblica Ceca 10
KE - Kenya 10
TN - Tunisia 10
VE - Venezuela 10
NP - Nepal 9
PE - Perù 9
ET - Etiopia 8
GR - Grecia 8
IL - Israele 8
CR - Costa Rica 7
DZ - Algeria 7
HN - Honduras 7
KG - Kirghizistan 7
UY - Uruguay 7
GT - Guatemala 6
HU - Ungheria 6
JO - Giordania 6
NI - Nicaragua 6
PY - Paraguay 6
TH - Thailandia 6
AL - Albania 5
BG - Bulgaria 5
CH - Svizzera 5
DO - Repubblica Dominicana 5
LB - Libano 5
PA - Panama 5
SI - Slovenia 5
SV - El Salvador 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EU - Europa 4
GH - Ghana 4
OM - Oman 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
MD - Moldavia 3
NO - Norvegia 3
PT - Portogallo 3
SN - Senegal 3
YE - Yemen 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
BZ - Belize 2
CI - Costa d'Avorio 2
GA - Gabon 2
HR - Croazia 2
KZ - Kazakistan 2
Totale 73.133
Salva come PNG Salva come JPEG
Città #
Woodbridge 15.550
Wilmington 15.053
Houston 13.919
Singapore 1.637
Fairfield 1.633
Ann Arbor 1.432
Ashburn 1.160
Chandler 1.084
San Jose 666
Seattle 652
Jacksonville 596
Hong Kong 572
Cambridge 541
Dublin 512
Beijing 478
Medford 421
New York 396
Helsinki 368
Council Bluffs 318
Dallas 318
The Dalles 301
Santa Clara 287
Los Angeles 264
Rome 202
Lawrence 195
Dearborn 193
Lauterbourg 147
Ho Chi Minh City 137
Moscow 135
Zhengzhou 124
Hanoi 117
Tokyo 107
Buffalo 100
Chicago 89
São Paulo 84
Menlo Park 79
San Diego 77
Boardman 76
Milan 72
Mülheim 71
Redwood City 70
London 62
Munich 54
Nanjing 53
Brussels 51
Toronto 49
Shanghai 46
Norwalk 43
Tauranga 42
Falls Church 41
North Bergen 41
Palo Alto 39
Seoul 39
Phoenix 38
Orem 37
Kraków 36
Nuremberg 36
Redondo Beach 35
Atlanta 34
Copenhagen 34
Amsterdam 33
Columbus 32
Stockholm 32
Warsaw 31
Chester 30
Johannesburg 30
Mountain View 30
Verona 30
Brooklyn 29
Guangzhou 29
Hefei 29
Frankfurt am Main 28
Shenzhen 28
Denver 27
Kunming 27
Chengdu 26
Jakarta 26
San Mateo 26
Melbourne 25
Montreal 25
Suzhou 25
University Park 24
San Francisco 23
Haiphong 22
Naples 22
Taipei 22
Chennai 21
Boston 20
Chongqing 20
Rio de Janeiro 19
Alexandria 17
Baghdad 17
Dong Ket 16
Augusta 15
Da Nang 15
Las Vegas 15
Washington 15
Belo Horizonte 14
Brasília 14
Curitiba 14
Totale 61.986
Salva come PNG Salva come JPEG
Nome #
Challenges in the treatment of Rheumatoid Arthritis 869
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 580
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis 566
Complement, infection, and autoimmunity 561
Complement and autoimmunity 536
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 533
Gonadal mosaicism in hereditary angioedema 532
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 521
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 519
Serum thymosin alpha 1 levels in normal and pathological conditions 516
Autoantibodies in inflammatory arthritis 514
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 512
NK cells in autoimmunity: A two-edg'd weapon of the immune system 510
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 508
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion 507
Glutathione: A key player in autoimmunity 506
Vasculitides and the Complement System: a Comprehensive Review 504
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 501
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 496
Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: Is it possible after disease remission? 491
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 490
Anti-thyroid antibodies and antiphospholipid syndrome: Evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters 490
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 490
Denaturing HPLC in laboratory diagnosis of hereditary angioedema 488
Evidence of impaired sense of smell in hereditary angioedema 488
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 487
An impaired endothelial dependent and independent vasodilation characterizes the myo-endothelial dysfunction in ssc patients 484
Apremilast for the treatment of psoriasis. 480
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 476
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 476
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 473
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 473
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 472
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 471
Adalimumab corrects long-term endothelial dysfunction in rheumatoid arthritis 469
The type I IFN system in rheumatoid arthritis 468
High-dose intravenous immunoglobulin treatment activates complement in vivo 467
Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors 465
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 463
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 463
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 461
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 460
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 460
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 458
Complement activation and sensitizing antibodies in lyme borreliosis - a microbial adherence immobilization assay for borrelia-burgdorferi (maia-bb) 458
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 458
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 456
Adalimumab and polymyalgia rheumatica. clinical remission but persisting high levels of esr: a controversy 456
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 455
The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies 453
Anti-Saccharomyces cerevisiae Autoantibodies in Autoimmune Diseases: from Bread Baking to Autoimmunity 453
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 453
Scleroderma heart involvement: non-invasive assessment of pathophysiological mechanism and its effect on prognosis 452
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 451
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine. 448
GM-CSF and pregnancy: Evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment 446
The European register of hereditary angioedema: Experience and preliminary results 443
Antimyocardial Autoantibodies (AMCA) 443
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: The experience of two Italian integrated Dermatology/Rheumatology outpatient clinics 440
Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab 440
Occurrence of localized scleroderma morphea in a patient with rheumatoid arthritis treated with etanercept 439
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 439
Small-medium vessel vasculitides: Is the complement system a potential forgotten target? 439
HELLP syndrome: A complication or a new autoimmune syndrome? 438
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 437
Auto-reactions, autoimmunity and psoriatic arthritis 436
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 435
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group 435
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 433
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 432
Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma. 431
European consensus for gynecologycal and obstetric management of women with hereditary angioedema due to C1-inhibitor deficiency (HAE): PREHAEAT 431
ADA genetic polymorphism and total plasma IgE level in healthy adults 429
Behcet's disease and etanercept: eighty weeks of experience 429
Cytokine production by human fetal membranes and uterine decidua at term gestation in relation to labor 429
Cystic ovaries in women affected with hereditary angioedema. 427
TREATMENT OF RECURRENT SPONTANEOUS ABORTION WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN 423
Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications 423
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 423
'Autoimmunity cutting edge at the 21st century. Representation of the 9th international congress of autoimmunity, nice, France 2014' 423
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 422
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 422
Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways 420
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis 419
The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency 419
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 417
BETA ENDORPHIN INTERACTION WITH LFA 1 (CD11A/CD18) ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES 417
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 417
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 416
Successful high dose intravenous immunoglobulin treatment of a pregnant patient affected with hypereosinophilia syndrome and antiphospholipid syndrome (aPL plus recurrent spontaneous abortion) 416
NK cells, autoantibodies, and immunologic infertility: a complex interplay 416
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implication 415
Insights on the role of physical activity in patients with rheumatoid arthritis 415
The interplay between inflammation and metabolism in rheumatoid arthritis 415
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 414
Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion: reply 412
Discontinuation of anti-TNFα therapy due to remission in rheumatoid arthritis: A retrospective study 412
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts 411
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 409
Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects 409
Totale 46.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 168.564
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 168.564
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.972 0 221 157 118 84 128 101 99 101 198 180 585
2022/20232.649 239 229 97 368 252 581 204 162 264 38 153 62
2023/20241.026 132 41 48 35 84 317 29 106 19 26 16 173
2024/20254.597 181 980 493 273 105 304 214 181 436 412 581 437
2025/20268.672 592 335 1.086 824 814 384 1.207 939 868 780 433 410
2026/2027823 441 382 0 0 0 0 0 0 0 0 0 0
Totale 73.901